A substantially moisture tight container and lid assembly for storing and packaging moisture-sensitive items comprising an assembly with a container and a lid, the lid is attached by a hinge to an upper housing portion of the container, the lid includes a lip seal member that depends downwardly from the lid, the lip seal member is configured to abut at least a portion of the interior side of the container when the lid is in the closed position resulting in a substantially moisture tight seal between the lid and the lid, and the container assembly further comprising a base portion and an upper housing portion, the upper housing portion is capable of being snap-fit into the base portion by employing a lip seal mechanism to form a substantially moisture-tight seal.

A pharmaceutical product includes a delivery syringe comprising a plastic receptacle and an oxygen-tight envelope which envelopes the delivery syringe in an oxygen-tight manner, wherein the plastic receptacle is filled with an oxygen-sensitive active pharmaceutical ingredient fluid and an inner surface of the plastic receptacle is siliconized at least in sections.

An oxygen absorbing agent composition including at least one type of a compound having an indane skeleton represented by the following general formula (1) and a transition metal catalyst: ##STR00001##

Provided is an oxygen detecting agent composition including a redox dye and a reducing agent, the redox dye being an inorganic substance.

The present invention provides a multilayer plastic container capable of effectively preventing the degradation of content and a reduction in flavor such as taste or aroma, which are caused by oxygen. The multilayer plastic container of the present invention is a multilayer plastic container having at least one oxygen-absorbing layer and at least one oxygen-blocking layer, wherein the oxygen-absorbing layer is a layer formed from a thermoplastic polyester resin composition comprising a thermoplastic polyester resin and an oxygen absorber, and the content of the oxygen absorber to the total mass of the thermoplastic polyester resin composition is 0.01% to 3% by mass, the oxygen-blocking layer is a layer formed from a polyamide resin composition comprising a polyamide resin, and the content of a transition metal selected from the group consisting of cobalt, copper, cerium, aluminum and manganese to the total mass of the polyamide resin composition is less than 10 ppm, and at least one of the oxygen-absorbing layers is arranged on a side more inside than the oxygen-blocking layer.

To provide an oxygen-absorbing polyester resin composition which exhibits excellent oxygen-absorbing capability even in the absence of transition metal catalyst without affected by the glass transition temperature of a polyester resin that is contained as a base resin. The oxygen-absorbing polyester resin composition including a base resin (A) which is a polyester resin, an oxygen-absorbing component (B) which is a compound having an unsaturated alicyclic structure, and an oxidation promotion component (C) for promoting the oxidation of the oxygen-absorbing component (B), said oxidation promotion component (C) being a compound having a benzyl hydrogen.

The present invention belongs to the field of pharmaceutical industry and relates to a dry pharmaceutical composition comprising Canagliflozin, as well as to a process for preparing the same. Such dry pharmaceutical composition is useful as a medicament, especially for the normalization of plasma glucose levels.

A method of treatment of plasma with a physiologically compatible spray dry stable acidic substance (SDSAS) prior to or contemporaneously with spray drying of the plasma that results in greater recovery and greater long-term stabilization of the dried plasma proteins as compared to spray dried plasma that has not be subject to the formulation method of the present invention, as well as compostions related to plasma dried by the methods of the present invention.

A packaging system for microarrays, such as microarrays of microneedles, comprising inner and outer pouches (500, 5000).

The invention relates to compounds of the structure of formula I and II:

##STR00001##

where X is selected from the group consisting of O, S and NH; Y, A and B are independently selected from the group consisting of N and CH; D, E and F are independently selected from the group consisting of CH, N, O and S; the symbol ---- represents a single or a double bond; and R.sub.1, R.sub.2 and R.sub.3 are independently selected from the group consisting of H, electron withdrawing groups and electron releasing groups. In other embodiments, the compounds are used as oxygen scavengers and in barrier compositions and articles.